HomeSLN • NASDAQ
Silence Therapeutics ADR Representing 3 Ord Shs
$24.01
After Hours:
$24.01
(0.00%)0.00
Closed: Mar 18, 5:00:33 PM GMT-4 · USD · NASDAQ · Disclaimer
US listed security
Previous close
$22.84
Day range
$22.83 - $24.61
Year range
$4.55 - $27.72
Market cap
1.13B USD
Avg Volume
309.81K
Financials
Income Statement
Revenue
Net income
(GBP)Dec 2023Y/Y change
Revenue
2.10M-55.95%
Operating expense
14.05M18.41%
Net income
-14.41M-4.72%
Net profit margin
-686.61-137.71%
Earnings per share
-0.12
EBITDA
-13.22M-21.43%
Effective tax rate
3.70%
Total assets
Total liabilities
(GBP)Dec 2023Y/Y change
Cash and short-term investments
54.03M-24.05%
Total assets
93.82M-12.72%
Total liabilities
76.77M-10.13%
Total equity
17.05M
Shares outstanding
46.50M
Price to book
53.12
Return on assets
-34.68%
Return on capital
-176.68%
Net change in cash
(GBP)Dec 2023Y/Y change
Net income
-14.41M-4.72%
Cash from operations
-11.87M11.50%
Cash from investing
382.00K102.33%
Cash from financing
9.92M22,445.45%
Net change in cash
-4.78M86.42%
Free cash flow
-5.73M49.44%
About
Silence Therapeutics, is a London-based pharmaceutical company formed in 1994. The company since its inception has pioneered the design and development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London. Wikipedia
Founded
1994
Employees
109
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu